Search results for " OS"

showing 10 items of 2643 documents

Advantages of surgical simulation in the surgical reconstruction of oncological patients

2018

Background Stereolithography, which consists of computer-aided designed/computer-aided manufactured (CAD-CAM) and computer simulations, is a manufacturing technologies used for the production of definitive models and prototypes printed in three dimensions, and is widely used in Oral and Maxillofacial Surgery. Surgical procedures using models made by these technologies offer several advantages. Material and Methods This article describes three clinical cases of our experiences with patients diagnosed with squamous cell carcinoma and mandibular osteosarcoma, who underwent surgical removal of the lesions and subsequent mandibular reconstruction with a free fibula graft using surgical guides. R…

medicine.medical_specialtyAdolescentmedicine.medical_treatmentOsteotomyMandibular osteotomyFree fibulastomatognathic systemSurgical removalHumansMedicineComputer SimulationMandibular reconstructionFibulaGeneral DentistryAgedOsteosarcomabusiness.industryResearchMiddle Aged:CIENCIAS MÉDICAS [UNESCO]SurgeryMandibular Neoplasmsstomatognathic diseasesSurgery Computer-AssistedOtorhinolaryngologyFibulaUNESCO::CIENCIAS MÉDICASCarcinoma Squamous CellOral and maxillofacial surgeryComputer-Aided DesignFemaleSurgeryOral SurgeryMandibular ReconstructionSurgical simulationbusinessMedicina Oral Patología Oral y Cirugia Bucal
researchProduct

CD34 and CD105 Microvessels in Resected Bone Specimen May Implicate Wound Healing in MRONJ

2021

Clinical treatment outcome of MRONJ (medication-related osteonecrosis of the jaw) surgery despite radical osseous removal and primary closure healing still shows differences in terms of outcome and disease recurrence. The study aims to assess the rate of angiogenesis of MRONJ lesions in order to understand the impact of angiogenesis and neoangiogenesis status on MRONJ surgical treatment outcome. This is the first study correlating microvessel density with prognosis in MRONJ surgically-treated patients. The immunohistochemical expression of CD34 and CD105 in MRONJ specimens obtained from surgically-treated patients was evaluated. The most vascularized areas detected by CD34 and CD105 were se…

medicine.medical_specialtyAngiogenesisHealth Toxicology and Mutagenesissurgical treatmentTreatment outcomeCD34MRONJArticleangiogenesismedicineHumansmedication-related osteonecrosis of the jawRadical surgeryRetrospective StudiesMicrovesselResected Bone SpecimenWound Healingbusiness.industryRPublic Health Environmental and Occupational HealthEndoglinmedicine.diseaseSurgeryCD105CohortMicrovesselstreatment outcomeMedicineBisphosphonate-Associated Osteonecrosis of the JawCD34Osteonecrosis of the jawWound healingbusinessInternational Journal of Environmental Research and Public Health
researchProduct

Review and update on drugs related to the development of osteonecrosis of the jaw

2019

Conflict of interest Conclusions of the working group on “New drugs related to the de-velopment of osteonecrosis of the jaw”. Spanish Society of Cranio-mandibular Dysfunction and Orofacial Pain and Spanish Society of Oral Medicine SEDCYDO-SEMO joint International Meeting: 30th SEDCYDO annual meeting & 15th SEMO Congress. Bilbao (Spain); June, 2019. [EN] Background: Medication-related osteonecrosis of the jaw (MRONJ) is a rare, but serious adverse effect of cer-tain drugs, of which bisphosphonates are the most widely known. This pathology is also associated with other medications such as the biologic antiresorptive agent, denosumab and some antiangiogenics such as sunitinib, bevacizumab or a…

medicine.medical_specialtyBevacizumabReviewMRONJ03 medical and health sciencesantiresorptives0302 clinical medicinemedicineHumansIntensive care medicineAdverse effectGeneral DentistrybisphosphonatesAfliberceptBisphosphonate-associated osteonecrosis of the jawOral Medicine and PathologyBone Density Conservation AgentsDiphosphonatesbusiness.industrySunitinibOsteonecrosis030206 dentistryEvidence-based medicinemedicine.disease:CIENCIAS MÉDICAS [UNESCO]osteonecrosis of the jawantiangiogenicsDenosumabOtorhinolaryngologyPharmaceutical PreparationsUNESCO::CIENCIAS MÉDICASSurgeryBisphosphonate-Associated Osteonecrosis of the JawDenosumabbusinessOsteonecrosis of the jawmedicine.drug
researchProduct

Current Controversies in Classification, Management, and Prevention of Bisphosphonate-Related Osteonecrosis of the Jaw

2014

Bisphosphonate-related osteonecrosis of the jaw (BRONJ) is a serious complication associated with oral and intravenous bisphosphonate therapy that adversely affects the quality of life, producing significant morbidity. Since the first description of bone necrosis in patients receiving bisphosphonate therapy in 2003 [1], hundreds of studies were published about this topic and various national and international medical societies have published protocols and guidelines. Nevertheless, there are still many controversies regarding the classification, management, and prevention of BRONJ. Even the definition of BRONJ is still debated and changed with the progress of knowledge and experience. Accord…

medicine.medical_specialtyBisphosphonate-associated osteonecrosis of the jawArticle Subjectbusiness.industrymedicine.medical_treatmentRetrospective cohort studyBisphosphonatemedicine.diseaseReview articleSurgeryBisphosphonate Osteonecrosis of the Jawlcsh:RK1-715EditorialDenosumablcsh:DentistryOral and maxillofacial pathologymedicineOral and maxillofacial surgeryIntensive care medicineOsteonecrosis of the jawbusinessGeneral Dentistrymedicine.drugInternational Journal of Dentistry
researchProduct

Comment on Medication-Related Osteonecrosis of the Jaw: MASCC/ISOO/ASCO Clinical Practice Guideline Summary

2020

medicine.medical_specialtyBisphosphonate-associated osteonecrosis of the jawOncology (nursing)business.industryHealth PolicyMEDLINEGuidelinemedicine.diseaseClinical PracticeOncologymascc isoo ascoo mrojHumansMedicineBisphosphonate-Associated Osteonecrosis of the JawbusinessOsteonecrosis of the jawIntensive care medicineJCO Oncology Practice
researchProduct

Improving adherence in osteoporosis: a new management algorithm for the patient with osteoporosis

2011

Introduction: Bisphosphonates are the first-choice treatment for osteoporosis. They effectively increase bone mineral density, reduce markers of bone resorption, and lower the incidence of new fractures in patients with osteoporosis-related fracture. However, the efficacy observed in clinical trials may not be realized in a real-life setting, partly due to poor adherence to therapy, with a significant worsening of clinical outcomes. Several issues contribute to poor adherence to osteoporosis medication, including inconvenient dosing regimens and concerns about possible adverse events. Although strategies to improve adherence have been investigated, new approaches are required. Areas covered…

medicine.medical_specialtyBone Density Conservation AgentBone densityOsteoporosisAlternative medicineadherence; osteoporosis; treatment algorithm; bone density; medication possession ratio; bisphosphonatesMedication AdherenceClinical ProtocolsCost of IllnessTreatment algorithmmedicineHumansBisphosphonatePharmacology (medical)DosingClinical ProtocolAdverse effectMED/01 - STATISTICA MEDICAOsteoporosis PostmenopausalAdherence bisphosphonates bone density medication possession ratio osteoporosis treatment algorithmMedication possession ratioPharmacologyBone Density Conservation Agentsbusiness.industryOsteoporosiGeneral Medicinemedicine.diseaseAlgorithmCost of IllneClinical trialBone Density Conservation AgentsTreatment OutcomeZoledronic acidAdherenceAdherence; Bisphosphonates; Bone density; Medication possession ratio; Osteoporosis; Treatment algorithm; Algorithms; Bone Density Conservation Agents; Clinical Protocols; Cost of Illness; Female; Humans; Osteoporosis; Osteoporosis Postmenopausal; Treatment Outcome; Medication Adherence; Pharmacology; Pharmacology (medical)Physical therapyOsteoporosisFemaleBone densitybusinessAlgorithmsHumanmedicine.drugExpert Opinion on Pharmacotherapy
researchProduct

Guidelines for the management of osteoporosis and fragility fractures

2018

The purpose of this document, a result of the harmonisation and revision of Guidelines published separately by the SIMFER, SIOMMMS/SIR, and SIOT associations, is to provide practical indications based on specific levels of evidence and various grades of recommendations, drawn from available literature, for the management of osteoporosis and for the diagnosis, prevention, and treatment of fragility fractures. These indications were discussed and formally approved by the delegates of the Italian Scientific Associations involved in the project (SIE, SIGG, SIMFER, SIMG, SIMI, SIOMMMS, SIR, and SIOT). The purpose of this document, a result of the harmonisation and revision of Guidelines publishe…

medicine.medical_specialtyBone densityOsteoporosis030204 cardiovascular system & hematologyEM - Original03 medical and health sciences0302 clinical medicineFragilityBone DensitymedicineSettore MED/33 - Malattie Apparato LocomotoreInternal MedicineHumans030212 general & internal medicineFractures; Osteoporosis; Therapy; Internal Medicine; Emergency Medicinebusiness.industryOsteoporosiEvidence-based medicinemedicine.diseaseFractures; Osteoporosis; TherapyFractureItalyFamily medicineEmergency MedicineOsteoporosisTherapybusinessFracturesOsteoporotic Fractures
researchProduct

The Effectiveness of Physical Exercise on Bone Density in Osteoporotic Patients

2018

Physical exercise is considered an effective means to stimulate bone osteogenesis in osteoporotic patients. The authors reviewed the current literature to define the most appropriate features of exercise for increasing bone density in osteoporotic patients. Two types emerged: (1) weight-bearing aerobic exercises, i.e., walking, stair climbing, jogging, and Tai Chi. Walking alone did not appear to improve bone mass; however it is able to limit its progressive loss. In fact, in order for the weight-bearing exercises to be effective, they must reach the mechanical intensity useful to determine an important ground reaction force. (2) Strength and resistance exercises: these are carried out with…

medicine.medical_specialtyBone densitylcsh:Medicine030209 endocrinology & metabolismPhysical exerciseReview ArticleWalkingVibrationGeneral Biochemistry Genetics and Molecular Biology03 medical and health sciences0302 clinical medicinePhysical medicine and rehabilitationBone DensityHumansMedicineWhole body vibrationAerobic exercise030212 general & internal medicineMuscle StrengthExercise physiologyGround reaction forceExerciseGeneral Immunology and Microbiologybusiness.industrySettore MED/34 - Medicina Fisica E RiabilitativaStair climbinglcsh:ROsteoporosiGeneral MedicineExercise TherapyOsteoporosisPhysical exercise BMD osteoporotic patients whole body vibrationBody regionbusinessHuman
researchProduct

Relationship between sleep disturbances and peripheral airway abnormalities in COPD patients

2017

Background: Individuals with COPD experience sleep disturbances due to the impact of symptoms on quality of sleep. Aim: To test the hypothesis that, in COPD, sleep disturbances are linked to peripheral airway abnormalities. Methods: An investigational study is being performed at the University of Palermo, Italy. The impact of breathing problems on quality of sleep during the previous week is measured with the COPD and Asthma Sleep Impact Scale (CASIS) questionnaire. Airway resistances by impulse oscillometry (IOS) assesses peripheral airway abnormalities. Lung function evaluation includes static and dynamic lung volume measurements. To rule out the risk of having obstructive sleep apnea, th…

medicine.medical_specialtyCOPDbusiness.industryAirway obstructionmedicine.diseaseAir trappingInterim analysisrespiratory tract diseasesObstructive sleep apneaImpulse OscillometryInternal medicinemedicineCardiologymedicine.symptomAirwaybusinessAsthmaClinical Problems Asthma
researchProduct

Osteoarthritis and mortality: a prospective cohort study and systematic review with meta-analysis

2016

Objectives: Osteoarthritis (OA) is a leading cause of disability, but the relationship with premature mortality remains uncertain. We aimed to investigate the relationship between OA and mortality from any cause and from cardiovascular disease (CVD).\ud \ud Methods: Electronic literature databases searches were conducted to identify prospective studies comparing mortality in a sample of people with and without OA. Risk of all-cause and CVD mortality were summarized using adjusted hazard ratios (HRs) for joint specific (hand, hip, and knee) and joint non-specific OA. New data from the Progetto Veneto Anziani (PRO.V.A.) study were also included. Results: From the PRO.V.A. study (N 1⁄4 2927), …

medicine.medical_specialtyCardiovascular disease; Mortality; Osteoarthritis; Rheumatology; Anesthesiology and Pain MedicineOsteoarthritisDiseaseComorbidity03 medical and health sciences0302 clinical medicineRheumatologycardiovascular diseaseRisk FactorsInternal medicineOsteoarthritismedicineHumans030212 general & internal medicineProspective StudiesMortalityProspective cohort study030203 arthritis & rheumatologybusiness.industryHazard ratioOsteoarthritis Mortality Cardiovascular diseasemedicine.diseaseCardiovascular diseaseR1ComorbiditymortalityRheumatologyosteoarthritisIncreased riskAnesthesiology and Pain MedicineCardiovascular DiseasesMeta-analysisPhysical therapybusinessCardiovascular disease; Mortality; Osteoarthritis
researchProduct